SCHEMBL6039495

SCHEMBL6039495

COc1cccc(-c2nccn2C2CCNCC2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.49
TDP1 Q9NUW8 1/20 0.49
ABL1 P00519 3/20 0.48
EGFR P00533 3/20 0.48
SRC P12931 3/20 0.48
ABL2 P42684 3/20 0.48
FYN P06241 1/20 0.47
HTR2C P28335 3/20 0.46
CYP2C19 P33261 3/20 0.46
MAPK14 Q16539 1/20 0.46
CYP3A4 P08684 3/20 0.44
HSD17B10 Q99714 3/20 0.44
LMNA P02545 2/20 0.44
MAPK1 P28482 2/20 0.44
KDM4E B2RXH2 2/20 0.44
NISCH Q9Y2I1 1/20 0.44
CLK4 Q9HAZ1 3/20 0.43
DYRK1A Q13627 1/20 0.43
BRD4 O60885 1/20 0.43
PLAT P00750 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28695130 0.88 ABL1 (0.51) ABL1EGFRSRCABL2KDM4E
SCHEMBL6039509 0.80 NSD3 (0.43) TDP1EGFRSRCMAPK14BRD4
SCHEMBL3651007 0.79 NR1H4 (0.47) MAPK14NISCHBRD4HTR3A
SCHEMBL3959958 0.73 HTR2C (0.48) CYP1A2TDP1ABL1EGFRSRC
Hydrochloric Acid SCHEMBL3250146 0.73 HTR2C (0.48) CYP1A2TDP1ABL1EGFRSRC
SCHEMBL5362756 0.73 DYRK1A (0.56) CYP1A2TDP1CYP2C19CYP3A4HSD17B10
SCHEMBL28851921 0.72 DYRK1A (0.54) CYP1A2TDP1CYP2C19CYP3A4HSD17B10
Trifluoroacetic Acid SCHEMBL16827760 0.72 NSD3 (0.39) MAPK14LMNA
SCHEMBL29664258 0.71 MAP4K4 (0.41) SRCHSD17B10KDM4EALDH1A1MAPT
SCHEMBL8098925 0.71 SRC (0.89) ABL1EGFRSRCABL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664042-A1 IMIDAZO 1,5-a PYRIDINE OR IMIDAZO 1,5-a PIPERIDINE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEDICAMENT AGAINST 5-HT2A RECEPTOR-RELATED DISORDERS Galapagos N.V. (BE) 2006-06-07 EP disclosed
WO-2005021545-A1 IMIDAZO[1,5-a]PYRIDINE OR IMIDAZO[1,5-a]PIPERIDINE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEDICAMENT AGAINST 5-HT2A RECEPTOR-RELATED DISORDERS GALAPAGOS NV (BE) 2005-03-10 WO disclosed